Calibrate vs. Found vs. Ro Body: Which Telehealth Weight Loss Program Delivers the Best Value?

Calibrate, Found, and Ro Body represent three distinct philosophies in telehealth weight loss. Calibrate bets on insurance navigation and structured coaching. Found emphasizes community and broad medication access. Ro Body focuses on brand-name medications with the lowest possible cash-pay pricing through manufacturer partnerships. Each has genuine strengths — but they serve different patients best.

Side-by-Side Comparison

Calibrate: The Insurance-Optimized Metabolic Reset

Calibrate's strength is clinical rigor paired with insurance expertise. Their dedicated navigation team routinely secures GLP-1 copays of $25 per month or less for commercially insured patients. The program's 52-week Metabolic Reset curriculum is structured around four pillars — food, sleep, exercise, and emotional health — with biweekly video coaching sessions that provide genuine accountability.

The 10% weight-loss money-back guarantee is a differentiator that signals confidence in their methodology. Their published outcomes (19% average weight loss at three years) are the best in the industry. But the $199 per month membership is the most expensive of the three, the program requires commercial insurance (no Medicare, Medicaid, or Tricare), and the three-month minimum commitment adds friction.

Best for: Patients with commercial insurance who want maximum clinical support, published outcome guarantees, and are willing to pay a premium for structured long-term coaching.

Found: Flexibility and Breadth

Found positions itself as the accessible option with pricing starting at $39 per month for basic access. Their medication formulary is the broadest of the three, including compounded semaglutide, brand-name GLP-1s, and non-GLP-1 oral options. This flexibility means more patients can find a medication pathway that fits both their medical profile and their budget.

Found's community features — peer support groups, shared progress tracking — add a social dimension that neither Calibrate nor Ro emphasizes. Their coaching model is more community-oriented than one-on-one, which works well for patients who draw motivation from group accountability but may feel less personalized.

The trade-off is less clinical depth. Found doesn't require lab work by default, doesn't offer an insurance navigation team comparable to Calibrate or Ro, and publishes less outcome data. For patients who want straightforward medication access with community support at a low monthly cost, Found delivers. For those who want rigorous medical oversight, the other two programs are stronger.

Best for: Budget-conscious patients who value medication flexibility and community support over intensive clinical oversight.

Ro Body: Brand-Name Medications at Cash-Pay Prices

Ro's defining advantage in 2026 is their integration with manufacturer direct-purchase programs. Through partnerships with LillyDirect (Zepbound vials) and NovoCare (Wegovy pens and pills), Ro members can access brand-name FDA-approved GLP-1 medications at prices that undercut most retail pharmacies. Lower-dose Wegovy pills start at $149 per month for new patients, and Zepbound vials begin at $299 per month.

The insurance concierge handles paperwork, prior authorizations, and coverage negotiations at no extra charge. Lab work at Quest locations is included in the membership. Monthly provider check-ins and a coaching curriculum round out the medical support. At $145 per month, Ro's membership sits between Found's budget pricing and Calibrate's premium.

Ro doesn't offer compounded medications, which means cash-pay patients without insurance are looking at $145 membership plus $149–$449 for medication per month — a total that can exceed Calibrate when brand-name medication costs run high. But for patients whose insurance covers GLP-1s, Ro's combination of low membership fees, included lab work, and aggressive insurance support makes it exceptionally competitive.

Best for: Patients who want FDA-approved brand-name medications with strong insurance support and manufacturer pricing partnerships.

The Direct Provider Alternative

All three programs share a common limitation: the total cost — membership plus medication — can exceed $300–$500 per month depending on your insurance situation. For patients who are self-directed and primarily want quality GLP-1 medication at a transparent price, direct providers offer a simpler and often cheaper pathway.

Our Verdict